Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.
Researchers analyzed 1,206 patient cases and found that OR reconstruction cases had a higher median baseline cost of $2,308 compared to $987 for clinic procedures.
Researchers introduce a biomarker to indicate whether someone is struggling with the inflexible thinking associated with the disorder.
Evaluating how genetic risk interacts with environmental risk factors such as sexual trauma is important for understanding how mental illness develops and identifying high-risk groups for early intervention.
The research team will analyze existing genome-wide association study data and RNA sequencing to compare fibroid development patterns in Nigerian women and U.S. Black women, which could point to targeted therapies and management strategies for affected women.